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60 pats received Heparin for 24 h and no oral anticoagulation beside aspirin
(100 mg tid) and ticlopidin (250 mg tid). During the post stent observation pe-
riod of 4 weeks no deaths, no subsequent myocardial infarction and no stent
occlusion occurred. Either bleeding or vascular complications were seen in
1 pat, respectively. In the 54 pats requiring coumadin therapy, there were 1
subacute stent occlusion, 1 death, 3 bleeding and 6 vascular complications.
Thus, IVUS guided optimized coronary Palmaz Schatz stent placement and
expansion without post procedural systemic anticoagulation is a safe and
effective therapeutic regimen.
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Combined Antiplatelet Therapy without
Anticoagulation: An Effective Alternative to
Prevent Subacute Thrombosis After Coronary
Stenting?
A 3 Month Follow-up
Restenosis within tubular-slotted stents is usually treated with repeat PTCA.
To understand the mechanisms of lumen enlargement after PTCA of in-stent
restenosis, we used quantitative angiography (measurement of % diameter
stenosis) and intravascular ultrasound to study 36 restenotic JJIS stents (7
native coronary and 29 vein graft) before and after repeat PTCA. Reference
segment and pre- and post-PTCA measurement of external elastic mem-
brane (EEM), stent, and lumen areas were used to calculate (1) plaque area,
(2) neointimal hyperplasia (IH) area within the stent (stent -lumen area), (3)
% area stenosis of lesion lumen area vs reference lumen area, (4) and %
area stenosis of stent area vs reference lumen area.
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Stent implantation is limited by the occurrence of subacute stent occlusion
and local complications related to anticoagulant therapy. Subacute closure
is usually delayed and may occur several weeks after stent implantation.
Recent data suggest that antiplatelet therapy might be an effective alterna-
tive to classical anticoagulation. We are prospectively studying the use of a
combined antiplatelet therapy without anticoagulation (heparin discontinued
within 48 hours and no coumadin) in consecutive and successful stent proce-
dures in our institution. All patients received aspirin 200 mg daily continued
indefinitely, dextran infusion during the procedure and for 4 days and ticlopi-
dine 500 mg daily begun within one hour following a successful procedure
and continued for 3 months.
The 3 month follow-up (range: 1-7 months) of the first 53 patients stented
during the first 10 months is presented. Stent implantation was required
mainly for failed PTCA (n = 50) including 41 cases for acute or threatened clo-
sure. These stent procedures represented 6.4% of total procedures during
this period. PTCA indications were stable angina (n = 18), unstable angina (n
= 18), recent myocardial infarction (n = 15) and acute myocardial infarction
In = 2). Sixty-seven stents were implanted (Wiktor, n = 50; Palmaz-Schatz, n
= 7; Gianturco-Roubin, n = 10) in 53 arteries (saphenous vein grafts, n = 2;
left anterior descending artery, n = 19; circumflex artery, n = 11; and right
coronary artery, n = 21 ). Mean stent diameter was 3.43 ± 0.34 mm (range:
2.5-4.0 mm).
There were no deaths. The dayolthe procedure, 3 patients had Q-wave MI
that were ongoing at the time of stenting, 3 patients developed non Q-wave
MI and 2 patients needed transfusion related to blood loss during the pro-
cedure. Between day one and discharge no patient had recurrent ischemia,
no patient needed emergent revascularization, vascular repair or blood trans-
fusion but one patient had elective CABG (2.4%). All patients were asymp-
tomatic at discharge after 7.4 ± 3 days. During the subsequent 3 month
follow-up no patient presented history of unstable angina, myocardial infarc-
tion, subacute thrombosis or emergent revascularization. One additional pa-
tient was referred for elective CABG (2.4%). Two patients developed rashes
and ticlopidine was discontinued (4.9%).
In regard to major clinical events, combined antiplatelet therapy using ticlo-
pidine plus aspirin is a promising alternative to classical anticoagulant ther-
apy to prevent delayed complications after successful stent implantation.
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A Cost Analysis of Intravascular Ultrasound
Guided Coronary Stenting without
Anticoagulation vs. the Traditional Method of
Stenting with Anticoagulation
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Stenting Method Traditional New P value
Age (Year) 58 ± 7 55 ± 7 OA4
Male(%) 19(95%) 16(80%) 018
Procedure Time (hr) 1.5 ± 0.5 1.3± OA 019
Procedure Cost ($) 8,513 ± 1,260 9,646 ± 3.129 0.18
Total Charge ($) 14,306 ± 2.494 11,733 ± 3.888 003
Hospitalization (days) 8±2 2±2 0.0001
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The major drawback of coronary stenting is the need to vigorous anticoagu-
lation. This study was to prospectively test the safety and efficacy of intravas-
cular ultrasound (IVUS) guided optimized stent placement without post pro-
cedural systemic anticoagulation. IVUS was intended in 105 pats with Pal-
maz Schatz stent placement after balloon angioplasty (PTCA) complicated
by progressive dissection (76 pats single stent; 28 multiple stents). After ac-
ceptable angiographic result. IVUS (2.9F; 30 MHz caths) was successfully
performed in 104/105 (99%) pats. IVUS criteria for optimal stent placement
were either a in-stent minimal lumen area (MLA) 2:90% of the reference MLA
andlor a in-stent MLA of 2:8.0 mm2 and a complete coverage of the dissec-
tion by stent. In a total of 14/104 (14%) these IVUS criteria were primarily
reached. In 90/104 (86%) balloon expansion (increased balloon seize; short
balloon; high pressure) was repeatedly performed. In 46 pats of this group
IVUS criteria were fulfilled. The additional acute lumen gain from 1st to final
IVUS trip was 2.3 ± 1.2 mm2 (37%). Thereby in a total of 60/1 04 (57%) pats
IVUS criteria could be reached and were confirmed by the finallVUS trip. All
all pts, serial quantitative angiographic follow-up (FU) study was performed
at 24 hours, 30 days and 6 months after stenting.
Optimal angiographic stent result was achieved in 98% of the lesions, and
minimal lumen diameter (MLD) increased from 1.2 ± 0.4 to 3.6 ± 0.5 mm
(p < 0.001). The aPTI remained normal (mean: 32 ± 5.6 sec, range: 24 to
48 sec) during LMWH administration; and an INR >2 was achieved 3 days
after intervention in 94% of stented pts. Neither an event (myocardial infarc-
tion. coronary surgery or death) nor major bleeding occurred during the first
month. At 24 hand 1 month angiographic FU, all stented lesions remained
patent, with no significant changes in MLD. At 6 months FU, all stented ar-
teries remained patent, MLD decreased significantly to 2.5 ± 0.8 mm (p <
0.001), and a restenosis rate of 23% (95% CI: 13-36%) of stented lesions
(stenosis 2:50% criteria) was observed.
These data suggest that, after elective stenting with optimal angiographic
result, the initial combination of LMWH (with no significant effect on aPTI)
plus anti platelet therapy, followed by anticoagulation with coumadin, prevent
subacute occlusion and bleeding complications, without detrimental effect
on previous reported restenosis rate.
Recently, the safety of intravascular ultrasound (IVUS) guided stent implan-
tation without subsequent anticoagulation has been established in 623 con-
secutive patients. The total incidence of stent thrombosis «3 weeks) and
bleeding complications is <1 %. This new method (N) generally requires 2
days hospital stay. The traditional method (T) requires 7 days hospital stay to
stabilize the anticoagulation regimen after stenting. Hospital charge for the
(T) and (N) method was retrospectively analyzed for single Palmaz-Schatz
coronary stent implantation. 20 consecutive patients with (T) before Jan 1,
1993 and 20 consecutive patient after Jan 1, 1994 with (N) were compared.
Patient age, gender, procedure time, procedure cost, hospitalization duration
(days), total charge (procedure, hospital and physician) and stent thrombosis
«1 month) were compared.
Conclusions. The new method: (1) may increase the procedure cost be-
cause IVUS and, sometimes, an extra balloon were required to optimize stent
expansion. (2) provided a significant reduction in the duration of hospitaliza-
tion. 3) decreases hospital stay and eliminates the expense of monitoring
for anticoagulation resulting in a significant reduction in total charges to the
patient.
